ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

 Click here to read this article as a CME activity

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
John W. Brown
Mark Ruzmetov
Palaniswamy Vijay
Mark D. Rodefeld
Mark W. Turrentine
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brown, J. W.
Right arrow Articles by Turrentine, M. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brown, J. W.
Right arrow Articles by Turrentine, M. W.
Related Collections
Right arrow Congenital - acyanotic

Ann Thorac Surg 2006;82:2221-2226
© 2006 The Society of Thoracic Surgeons

Original Articles: Cardiovascular

Surgical Treatment of Absent Pulmonary Valve Syndrome Associated With Bronchial Obstruction

John W. Brown, MD*, Mark Ruzmetov, MD, PhD, Palaniswamy Vijay, MPH, PhD, Mark D. Rodefeld, MD, Mark W. Turrentine, MD

Section of Cardiothoracic Surgery, Indiana University School of Medicine, and James Whitcomb Riley Hospital for Children, Indianapolis, Indiana

Accepted for publication July 11, 2006.

* Address correspondence to Dr Brown, Section of Cardiothoracic Surgery, Indiana University School of Medicine, 545 Barnhill Dr., EH 215, Indianapolis, IN 46202-5123 (Email: jobrown{at}iupui.edu).

Presented at the Poster Session of the Forty-second Annual Meeting of The Society of Thoracic Surgeons, Chicago, IL, Jan 30–Feb 1, 2006.


Pediatric cardiac surgery: The Annals of Thoracic Surgery CME Program is located online at http://cme.ctsnetjournals.org. To take the CME activity related to this article, you must have either an STS member or an individual non-member subscription to the journal.

 

   Abstract
Top
 Abstract
Introduction
 Material and Methods
 Results
 Comment
 References
 
BACKGROUND: Absent pulmonary valve syndrome (APVS) is a relatively rare anomaly that is usually associated with a ventricular septal defect and a restrictive pulmonary annulus with severe pulmonary regurgitation. The to-and-fro flow across the right ventricular outflow tract produces enormously dilated and pulsatile pulmonary arteries (PAs) that cause severe respiratory distress and tracheomalacia by compression of the trachea and primary bronchi. This retrospective study summarizes our 20-year experience of surgical treatment in patients with APVS.

METHODS: Between 1984 and 2005, 20 patients underwent repair of APVS using a valved conduit (n = 9), transannular patch (TAP) insertion alone (n = 5), or TAP with monocusp valve (n = 6) with PA reduction arterioplasty. Median age was 7 months (range, 6 days to 9 years).

RESULTS: There were one perioperative and two late deaths. All deaths were related to airway complications. Survival was 90% at 1 year and 85% at 10 and 15 years. In a multivariate analysis only preoperative ventilator dependency was associated with a worse outcome (p = 0.02). Follow-up was available in 18 operative survivors (mean follow-up, 7.3 ± 5.2 years). Six patients (33%) underwent reoperation for pulmonary valve incompetence and right ventricular dysfunction. Three patients (17%) had episodic bronchospasm of mild to moderate severity that were responsive to sympathomimetic bronchodilators.

CONCLUSIONS: Morbidity associated with perioperative respiratory complications and ventilator dependency due to underlying tracheobronchomalacia is an important problem in patients with APVS. These infants may require multiple hospitalizations for recurrent respiratory infections secondary to their tracheobronchomalacia. Complete repair with a valved conduit and reduction pulmonary arterioplasty at the onset of symptoms and a definitive diagnosis is our procedure of choice for infants with APVS. With this approach, the airway can be optimized to give the best patient outcome.

Absent pulmonary valve syndrome (APVS) is a rare malformation in which the pulmonary valve is absent or rudimentary. Rarely isolated, it is associated in most cases with a malalignment type of ventricular septal defect (VSD), right ventricular hypertrophy, or stenotic pulmonary annulus and is therefore classified as a variant of tetralogy of Fallot (TOF). The characteristic feature of this syndrome is aneurysmal pulmonary arteries (PAs) leading to obstruction of the bronchial tree with severe respiratory distress, especially in the neonatal period [1–3].

Operative treatment remains a controversial subject. There is no consensus whether a pulmonary valve should be inserted or how the size of the PA should be reduced [3–6]. Mortality for surgical repair in these patients is increased, especially in infants presenting with severe respiratory compromise [3, 5, 6]. Previous reports have shown improved early outcome when plication of the dilated pulmonary arteries is performed to relieve airway obstruction [3, 5, 6]. Persistent respiratory symptoms and the need for reoperation years later to replace a dysfunctional pulmonary valve are problems associated with this patient population. The purpose of this study is to report our surgical experience, since 1984, with a consecutive series of patients with absent pulmonary valve syndrome.


   Material and Methods
Top
 Abstract
 Introduction
 Material and Methods
Results
 Comment
 References
 
Between January 1984 and October 2005, 20 patients were operated on for TOF with APVS at the Riley Children’s Hospital in Indianapolis, Indiana (Fig 1). Median age was 7 months (range, 6 days to 9 years; mean, 28 ± 33 months) and median weight was 6.6 kg (range, 2.4 to 38 kg; mean, 11 ± 9.3 kg). There were 10 girls and 10 boys. A review of each patient’s complete medical record was performed. Follow-up data were obtained from the medical records and through correspondence from the patients’ cardiologists. This study has been approved and the Indiana University Institutional Review Board waived the need to obtain patient consent for this study.


Figure 1
View larger version (18K):
[in this window]
[in a new window]

  		Fig 1. Distribution and disposition of patients with tetralogy of Fallot with absent pulmonary valve syndrome who underwent various surgical repairs. (APVS = absent pulmonary valve syndrome; RV-PA = right ventricular to pulmonary artery; PTFE = polytetrafluoroethylene.)

 
A large spectrum in the severity of symptoms was observed among patients. Patients could be classified into two groups according to their age at operation and time of surgery. The infant group consisted of 11 patients less than 1 year of age. All infants were operated on after 1993 and were markedly symptomatic with severe respiratory distress, episodes of respiratory obstruction, and bronchopulmonary infection requiring repeated hospital admissions. Eight required mechanical ventilation preoperatively. Older children (more than 1 year old; n = 9) had milder respiratory or cardiac symptoms but significant bronchial obstruction which was confirmed by bronchoscopy preoperatively in five of them.

Clinical findings in both groups included a pansystolic murmur and low-pitched diastolic murmur at the left sternal border, varying degrees of cyanosis, and tachypnea. Second pulmonary sound P2 was absent. Chest X-ray showed cardiomegaly and gross dilatation of the main, left, and right pulmonary arteries in all patients. Pulmonary vascularity was normal or slightly reduced. All infants and children underwent two-dimensional echocardiography and Doppler assessment and 10 had a cardiac catheterization and angiography.

Associated intracardiac malformations were present in 10 of the 20 patients (50%), including ostium secundum type of atrial septal defect (n = 8), patent ductus arteriosus (n = 1), left superior vena cava (n = 1), absent left pulmonary artery (n = 1), single coronary artery of the left descending coronary artery crossing the RVOT (n = 1), and multiple aortopulmonary collaterals (n = 1). Four patients had extracardiac anomalies including DiGeorge syndrome (n = 1), Goldenhar syndrome (n = 1), CHARGE syndrome (a syndrome of associated defects, including coloboma of the eye, heart anomaly, choanal atresia, retardation, and genital and ear anomalies) (n = 1), and VATER syndrome (vascular anomalies, anal atresia, tracheoesophageal fistula, esophageal atresia, and renal anomalies) (n = 1).

Operative Technique
Operative repair was performed through a median sternotomy with aortobicaval cannulation, continuous cardiopulmonary bypass, hypothermia at 26°C to 28°C, and intermittent dose cold blood potassium cardioplegia. Extracorporeal circulation time ranged from 112 to 198 minutes (mean, 151 ± 27 minutes) and aortic cross-clamping time ranged from 31 to 123 minutes (mean, 74 ± 29 minutes). The right atrium was opened and patent foramen ovale or atrial septal defect was closed by patch or direct suture. In 2 infants a small atrial septal defect was left open. This was done in anticipation of high right-sided pressures postoperatively. A vertical infundibulotomy was then performed and the intracardiac anatomy was defined (Fig 2). Right ventricular outflow tract (RVOT) relief was achieved by resection of the hypertrophied infundibular muscle bands. The VSD was then closed using an elastic Dacron (C.R. Bard, Haverhill, PA) patch (n = 11) or Gore-Tex (W.L. Gore & Assoc, Flagstaff, AZ) patch (n = 9) anchored with interrupted pledgeted sutures. Ventricular septal defect closure was done through the right ventriculotomy in all cases.


Figure 2
View larger version (28K):
[in this window]
[in a new window]

  		Fig 2. (A) Line of resection of main pulmonary artery and anterior portion of main branches. Pulmonary artery is transected at annulus and incision is made into the right ventricular outflow tract. (B) Arterioplasty of right and left pulmonary artery branches reduces their caliber. (C) Completed repair using bovine jugular vein conduit.

 
Reduction pulmonary arterioplasty was performed in all patients (Table 1). An anterior arterioplasty was limited to the main pulmonary artery (n = 5) and the main, right, and left PAs (n = 14), and anterior reduction and posterior plication of the main, right, and left PAs with pulmonary arterioplasty was performed in one. The posterior wall of the PAs and their attachment to the bronchi were left undisturbed. The RVOT reconstruction, including the arterioplasty, was performed with the cross-clamp off and the heart beating in most cases.


View this table:
[in this window]
[in a new window]

  		Table 1. Type of RVOT and PA Reconstruction in Children With Absent Pulmonary Valve Syndrome
 
The RVOT was reconstructed with a transannular patch alone in 5 patients (all before 1993). A transannular patch was performed with Gore-Tex (W.L. Gore & Assoc) in 4 patients and with autologous pericardium in one patient. A polytetrafluoroethylene (PTFE) monocusp patch was inserted in 6 children beginning in 1993 (Table 1). In the remaining 9 patients, reconstruction included RV-PA conduit, a cryopreserved valved pulmonary homograft (CryoLife Inc, Kennesaw, GA; n = 6), jugular vein valved Contegra conduit (Medtronic Inc, Minneapolis, MN; n = 2), and nonvalved Hemashield graft (Meadox Medical Inc, Oakland, NJ; n = 1). The size of conduit varied from 10 to 26 mm (mean, 14.6 ± 4.7 mm). A conduit was first anastomosed distally to the PA bifurcation and then proximally to the RVOT using a running polypropylene suture. Most of the surgeries in infants were done on an urgent basis. The proximal conduit reconstruction was performed with a Gore-Tex hood. Intraoperative transesophageal echocardiography was done in the last 11 patients to assess adequacy of repair; it was not available for the first 9 patients.

In one patient, the left PA was discontinuous with the main PA and supplied by a patent ductus arteriosus. Reimplantation of the left PA to the pulmonary trunk and patent ductus arteriosus ligation were performed. In 2 patients (before 1990), correction of the APVS was performed as a two-stage repair. The first stage procedure was palliative and was described by Litvin and colleagues [7]. The right PA was divided at its origin from the main PA and brought anterior to the ascending aorta. It was reattached to the main PA with a short interposition 10 mm Dacron graft. At a second stage (3 and 7 years after initial surgery), correction of the APVS was accomplished using a large (16 mm) Dacron graft.

Statistical Analysis
The SPSS statistical program for Windows version 10 (SPSS, Inc, Chicago, IL) was used to perform the data analysis. Data are expressed as mean, median, and range. Actuarial estimates of freedom from postoperative events were accomplished with Kaplan-Meier methods and p values for differences between distributions were obtained by log-rank testing. Factors evaluated in multivariate analysis for risk of mortality and reoperation included age, weight, sex, date of operation, cardiopulmonary bypass and aortic cross-clamping time, preoperative ventilator dependency, preoperative severe respiratory distress, associated cardiac or noncardiac syndromes, previous cardiac operations, concomitant cardiac operations, type of PA reduction, type of RVOT reconstruction, and size of conduit. The analyses were performed with Cox proportional hazards regression. A forward step-wise selection method was used to add variables to the model requiring significance at p less than 0.10 for entry and p less than 0.05 for retention. Early death is defined as death in the hospital or death within 30 days after the procedure. All other deaths are considered late.


   Results
Top
 Abstract
 Introduction
 Material and Methods
 Results
Comment
 References
 
Survival
There was one perioperative and two late deaths. One patient died early despite extracorporeal membrane oxygenation support for low cardiac output. Both late deaths were related to airway complications. The first late death occurred two months after initial surgery due to aspiration and pneumonia. The second late death occurred in a child three months after initial surgery due to bronchopneumonia and sepsis. All three had required preoperative mechanical ventilation and were infants less than 40 days of age at the time of surgery.

Overall survival was 90% at 1 year and 85% at 5 and 10 years. Overall mortality was associated with a longer aortic cross-clamp time (p = 0.002), younger age at operation (p = 0.001), and preoperative ventilator dependency (p < 0.001). In a multivariable analysis, only preoperative ventilator dependency was associated with a worse outcome (p = 0.02).

The duration of mechanical ventilation after repair varied from 1 to 34 days (mean, 6 ± 7 days) and the intensive care unit stay varied from 4 to 52 days (mean, 8 ± 13 days). The postoperative course was completely uneventful in 16 children (7 infants and 9 older children). Recovery from respiratory distress was delayed in 2. One infant required plication of the left diaphragm and one had pneumonia requiring mechanical ventilation for 34 days. Surgical treatment has been offered at an earlier age in patients since 1993 compared with a group of patients prior to 1993 (p = 0.001). Infants were more likely to be intubated preoperatively (p < 0.001). Patients were more likely to undergo branch anterior pulmonary artery arterioplasty after 1993 (82%) than before 1993 (p = 0.02).

Follow-Up
Nineteen patients, including 10 infants survived the initial surgical procedure. Follow-up was available on 18 of 19 survivors. One patient (first in our series, who underwent initial surgery in 1984) was lost at follow-up nine years after surgery. The follow-up interval ranged from 3 months to 15 years (mean, 7.3 ± 5.2 years).

All surviving patients are currently well without physical limitations. Of the 16 late surviving patients, New York Heart Association (NYHA) functional class was markedly improved with 14 patients in class I, and 2 in class II. All patients are in normal sinus rhythm and 2 have right bundle branch block. Persistent respiratory symptoms including reactive airway disease with respiratory tract infection requiring at least periodic medication (bronchodilators) was noted in three survivors, all of whom underwent surgery as infants. Symptoms have tended to lessen with time. No patients require assisted ventilation or were discharged with a tracheostomy. No patients underwent reoperation for worsening respiratory symptoms.

Reoperation
Six of 18 patients (33%) have required reoperations during the follow-up period (Fig 3). The mean interval between initial procedure and reoperation was 5.5 ± 2.7 years (range, 2 to 9 years). The indications for the reoperation was RV-PA conduit insufficiency or stenosis (n = 4), and PTFE monocusp insufficiency (n = 2). The systolic RV-PA conduit gradient ranged from 35 to 80 (mean, 57 ± 22 mm Hg). Two patients with PTFE monocusp patch and 2 patients with cryopreserved pulmonary homograft underwent reoperation with the Contegra conduit (n = 4). Another two patients with cryopreserved pulmonary homograft underwent PTFE monocusp patch enlargement. The time interval between patients with PTFE monocusp patch and pulmonary homograft conduit insertion was significantly different (8.5 ± 0.7 years versus 4 ± 1.8 years; p = 0.03).


Figure 3
View larger version (10K):
[in this window]
[in a new window]

  		Fig 3. Freedom for reoperation in patients with absent pulmonary valve syndrome estimated by the Kaplan-Meier method. ({diamondsuit} = overall; {blacksquare} = right ventricle to pulmonary artery conduit; {blacktriangleup} = polytetrafluoroethylene; bullet = transannular patch.)

 
Overall freedom from RVOT reoperation estimated by the Kaplan-Meier method was 83% at 5 years and 66% at 10 and 15 years. Univariate and multivariate analysis showed the presence of a PTFE monocusp patch (p = 0.04) and cryopreserved pulmonary homograft insertion (p = 0.001) as the best predictor for the need for RVOT reoperation.


   Comment
Top
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
References
 
Tetralogy of Fallot with an absent or rudimentary pulmonary valve is a rare congenital cardiac malformation comprising 3% to 5% of all cases of the tetralogy complex. In 1847, Chevers was the first to describe this syndrome [8], which included a large VSD and stenosis at the PA annulus with or without narrowing of the right ventricular infundibulum, and two additional unique features, pulmonary regurgitation secondary to an absent or rudimentary pulmonary valve and aneurysmal dilatation of the pulmonary trunk and the main pulmonary arterial branches.

The pathogenesis of this syndrome is still controversial as the structural microscopic findings of the pulmonary artery wall are variable according to different studies [3, 4, 9]. Embryologic studies implicate an absent ductus arteriosus causing fetal pulmonary regurgitation that leads to massively dilated PAs and tracheobronchial compression [3, 10]. In 1990, Momma and colleagues [11] created an experimental model of tetralogy of Fallot with an absent pulmonary valve in rats treated by bis-diamine, a teratogen interfering with neural crest cells. These authors found that enlargement of the PAs was already present in utero and was correlated with a lesser degree of pulmonary annulus stenosis. Moreover, they noticed compression and deformity of the bronchial tree already during fetal life.

Patients with this syndrome can be divided into two groups depending on age and severity of symptoms. The first group comprises infants with severe cardiorespiratory distress. The results of medical and surgical treatment in this group have generally been poor. Many die of a combination of intractable heart failure and airway obstruction resulting from compression of the bronchi by massively dilated pulmonary arteries. Medical treatment often fails to control the symptoms and the various surgical procedures have had a high mortality. In severely ill infants, obtaining respiratory stability is the first priority. Postural drainage, air humidification, nebulizer therapy, and intubation with mechanical ventilation with high positive end-expiratory pressure (10 cm H2O) are initiated as required.

The second group includes older patients with mild symptoms who survive infancy. In these patients, closure of the VSD and relief of pulmonary stenosis can be performed later on an elective basis with low risk.

In infants with TOF and APVS who present with severe respiratory problems, a number of palliative and reparative operations were introduced during the 1960s and 1970s. Palliative procedures included tacking-up the PAs or the aorta to the sternum, transecting the right pulmonary artery and reattaching it to the pulmonary trunk in front of the aorta [7], creation of a classic Glenn shunt [12], reducing the size of the PAs [2, 13], lobectomies of collapsed or emphysematous lungs [1], and ligation or banding of the pulmonary trunk with construction of a central shunt [1, 14, 15]. For many years, ligation or banding of the pulmonary artery with construction of systemic-to-pulmonary artery shunt was the procedure of choice in these ill infants [16, 17]. We used Litvin’s palliative method in our two patients. Complete correction before the 1980s was mostly reserved for older less symptomatic children. Recently a more aggressive approach focusing on complete repair of these severely ill neonates and infants has yielded improved results and these are shown in Table 2 [3–6, 9, 18, 19, 24].


View this table:
[in this window]
[in a new window]

  		Table 2. Recent Reports of Tetralogy of Fallot With Absent Pulmonary Valve Syndrome
 
We agree with most authors that reduction PA arterioplasty is needed in most patients. However, there is no general consensus whether a pulmonary valve, or a valved or nonvalved conduit, should be inserted and the degree of size deduction of PAs. McCaughan and colleagues [20] recommended insertion of a pulmonary valve and plication of aneurysmal PAs in infants with APVS. In older children, they believe both these steps are not necessary. Ilbawi and colleagues [17] recommended pulmonary valve insertion in the older patients group, and for infants they prefer palliation first. Insertion of a valved conduit was also recommended by Snir and colleagues [9] and Dodge-Khatami and colleagues [4], whereas others [3, 18] place more emphasis on reduction of pulmonary artery size by anterior resection and posterior plication.

We have always treated patients with APVS by closing the ventricular septal defect; however, our approach to the pulmonary valve varied over time. Before 1992, the children tended to be older at time of surgery; since 1993, 11 of 13 patients have undergone surgery as neonates and infants. Before 1990, pulmonary valve implantation was not done and the RVOT was reconstructed with a transannular patch in all patients. Since 1991, all patients have undergone combined anterior PA reduction and insertion of either a valved conduit or PTFE monocusp outflow tract patch. Since 2000, we have used a fairly uniform technique consisting of VSD closure, placement of a right ventricle to pulmonary artery conduit (usually Contegra), and reduction of the size of the PAs. One patient had the addition of a posterior wall plication as suggested by Stellin and colleagues [18].

Despite advances in surgical techniques for repair of the cardiac lesions in TOF and APVS, survival remains less than ideal in many instances due to respiratory compromise from tracheobronchomalacia. The standard medical therapy for this has been positive pressure ventilation with or without a tracheostomy. There were few other techniques to relieve respiratory symptoms of the APVS: placement of bilateral Palmaz bronchial stents [21, 22], external stabilization using ring-reinforced PTFE prostheses [23], or balloon expandable metallic stents [4]. We have not used endobronchial stents as a treatment option in this setting.

Tetralogy of Fallot with APVS is a well-recognized distinct clinical entity that may present early in life as a surgical emergency. Morbidity associated with postoperative respiratory complications and ventilator-dependency due to underlying tracheobronchomalacia is an important problem in patients with APVS. These infants may require multiple postoperative hospitalizations for recurrent respiratory infections secondary to their tracheobronchomalacia. Complete repair with a valved conduit and reduction pulmonary arterioplasty in infancy at the time of symptom onset is the procedure of choice for infants with APVS. With this approach the patient outcome is determined by the status and management of their airway. Long-term follow-up is necessary for this subgroup.


   References
Top
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 References
 

  1. Stafford EG, Mair DD, McGoon DC, Danielson GK. Tetralogy of Fallot with absent pulmonary valve: surgical considerations and results Circulation 1973;48(suppl 1):III24-III30.[Medline]
  2. Miller RA, Lev M, Paul MH. Congenital absence of the pulmonary valveThe clinical syndrome of tetralogy of Fallot with pulmonary regurgitation. Circulation 1962;26:266-278.[Abstract/Free Full Text]
  3. Godart F, Houyel L, Lacour-Gayet F, et al. Absent pulmonary valve syndrome: surgical treatment and considerations Ann Thorac Surg 1996;62:136-142.[Abstract/Free Full Text]
  4. Dodge-Khatami A, Backer CL, Holinger LD, Baden HP, Mavroudis C. Complete repair of tetralogy of Fallot with absent pulmonary valve including the role of airway stenting J Card Surg 1999;14:82-91.[Medline]
  5. McDonnell BE, Raff GW, Gaynor JW, et al. Outcome after repair of tetralogy of Fallot with absent pulmonary valve Ann Thorac Surg 1999;67:1391-1396.[Abstract/Free Full Text]
  6. Watterson KG, Malm TK, Karl TR, Mee RBB. Absent pulmonary valve syndrome: operation in infants with airway obstruction Ann Thorac Surg 1992;54:1116-1119.[Abstract]
  7. Litvin SB, Rosenthal A, Fellows K. Surgical management of young infants with tetralogy of Fallot, absence of the pulmonary valve, and respiratory distress J Thorac Cardiovasc Surg 1973;65:552-558.[Medline]
  8. Chevers N. Recherches sur les maladies de l’artere pulmonaire Arch Gen Med 1847;15:488-508.
  9. Snir E, de Leval MR, Elliott MJ, et al. Current surgical technique to repair Fallot’s tetralogy with absent pulmonary valve syndrome Ann Thorac Surg 1991;51:979-982.[Abstract]
  10. Fouron JC, Sahn DJ, Bender R, et al. Fetal cardiac morphology of tetralogy of Fallot with absent pulmonary valve Am J Cardiol 1989;64:547-549.[Medline]
  11. Momma K, Ando M, Takao A. Fetal cardiac morphology of tetralogy of Fallot with absent pulmonary valve in the rat Circulation 1990;82:1343-1351.[Abstract/Free Full Text]
  12. Waldhausen JA, Friedman S, Nicodemus H, Miller W, Rashkind W, Johnson J. Absence of the pulmonary valve in patients with tetralogy of Fallot: surgical management J Thorac Cardiovasc Surg 1969;57:669-674.[Medline]
  13. Bove EL, Shaher RM, Alley RM, McKneally M. Tetralogy of Fallot with absent pulmonary valve and aneurysm of the pulmonary artery: report of two cases presenting as obstructive lung disease J Pediatr 1972;81:339-343.[Medline]
  14. Opie JC, Sandor GG, Ashmore PG, Patterson MW. Successful palliation by pulmonary artery banding in absent pulmonary valve syndrome with aneurismal pulmonary arteries J Thorac Cardiovasc Surg 1983;85:125-128.[Abstract]
  15. Park MK, Trinkle JK. Absent pulmonary valve syndrome: a two-stage operation Ann Thorac Surg 1986;41:669-671.[Abstract]
  16. Byrne JP, Hawkins JA, Battiste CE, Khoury GH. Palliative procedures in tetralogy of Fallot with absent pulmonary valve: a new approach Ann Thorac Surg 1982;33:499-502.[Medline]
  17. Ilbawi MN, Fedorchik J, Muster A, et al. Surgical approach to severely symptomatic newborn infants with tetralogy of Fallot and absent pulmonary valve J Thorac Cardiovasc Surg 1986;91:584-589.[Abstract]
  18. Stellin G, Jonas RA, Goh TH, Brawn WJ, Venables AW, Mee RB. Surgical treatment of absent pulmonary valve syndrome in infants: relief of bronchial obstruction Ann Thorac Surg 1983;36:468-475.[Abstract]
  19. Hew CC, Daebritz SH, Zurakowski D, del Nido PI, Mayer JE, Jonas RA. Valved homograft replacement of aneurismal pulmonary arteries for severely symptomatic absent pulmonary valve syndrome Ann Thorac Surg 2002;73:1778-1785.[Abstract/Free Full Text]
  20. McCaughan BC, Danielson GK, Driscoll DJ, McGoon DC. Tetralogy of Fallot with absent pulmonary valve: early and late results of surgical treatment J Thorac Cardiovasc Surg 1985;84:280-287.
  21. Filler RM, Forte V, Fraga JC, Matute J. The use of expandable metallic airway stents for tracheobronchial obstruction in children J Pediatr Surg 1995;30:1050-1056.[Medline]
  22. Subramanian V, Ansted M, Cottrill CM, Kanga J, Gurley J. Tetralogy of Fallot with absent pulmonary valve and bronchial compression: treatment with endobronchial stents Pediatr Cardiol 1997;18:237-239.[Medline]
  23. Hagl S, Jakob H, Sebening C, et al. External stabilization of long-term tracheobronchomalacia guided by intraoperative bronchoscopy Ann Thorac Surg 1997;64:1412-1421.[Abstract/Free Full Text]
  24. Brown JW, Ruzmetov M, Vijay P, Rodefeld, MD, Turrentine MW. Surgical treatment of absent pulmonary valve syndrome associated with bronchial obstruction Ann Thorac Surg 2006;82:2221-2226.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
 Ann. Thorac. Surg.Home page
J. W. Brown, M. Ruzmetov, P. Vijay, M. D. Rodefeld, and M. W. Turrentine
Surgical Treatment of Absent Pulmonary Valve Syndrome Associated With Bronchial Obstruction
Ann. Thorac. Surg., December 1, 2006; 82(6): 2221 - 2226.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
John W. Brown
Mark Ruzmetov
Palaniswamy Vijay
Mark D. Rodefeld
Mark W. Turrentine
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brown, J. W.
Right arrow Articles by Turrentine, M. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brown, J. W.
Right arrow Articles by Turrentine, M. W.
Related Collections
Right arrow Congenital - acyanotic

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS